3 Humongous Health-Care Stocks This Week
Who are the happiest investors in all of health care this week? Geron, Align, and athenahealth shareholders are all smiles.
Why Veeva Systems, Geron, and MGIC Investment Soared Today
Veeva, Geron, and MGIC posted impressive performances today. Find out why.
3 Things Investors Need to Watch With Geron
Can Geron compete with Cell Therapeutics, Gilead, and Sanofi in the battle to dislodge Incyte's myelofibrosis drug Jakafi? Here are 3 key things investors must watch.
Incyte Has First-Mover Advantage
Here's how Incyte's FDA-approved drug Jakafi for myelofibrosis stacks up to drugs from Sanofi and Geron.